Pharmacological inhibition of EZH2 by GSK126 decreases atherosclerosis by modulating foam cell formation and monocyte adhesion in apolipoprotein E‑deficient mice
Xianjing Wei(Affiliated Zhongshan Hospital of Dalian University), Xiaoqing Wang(Harvard University)
Cited by 24
Related Papers
CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice
|Molecular Medicine Reports|2016|17
PPARδ agonist protects against osteoarthritis by activating AKT/mTOR signaling pathway-mediated autophagy
|Frontiers in Pharmacology|2024|4
<i>In Vivo</i> CRISPR Screens Identify E3 Ligase Cop1 as a Modulator of Macrophage Infiltration and Cancer Immunotherapy Target
|bioRxiv (Cold Spring Harbor Laboratory)|2020|1